デフォルト表紙
市場調査レポート
商品コード
1797022

生物学的安全キャビネット市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、エンドユーザー別、地域別、競合別、2020年~2030年

Biological Safety Cabinet Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Type, By End User, By Region and Competition, 2020-2030F


出版日
ページ情報
英文 180 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.42円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

生物学的安全キャビネット市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、エンドユーザー別、地域別、競合別、2020年~2030年
出版日: 2025年08月25日
発行: TechSci Research
ページ情報: 英文 180 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

生物学的安全キャビネットの世界市場は、2024年には2億8,726万米ドルとなり、予測期間中のCAGRは8.00%で、2030年には4億5,587万米ドルに達すると予測されています。

生物学的安全キャビネットの世界市場は、伝染病リスクの高まりとバイオテクノロジーおよび製薬企業における研究開発活動の活発化により、大きな成長を遂げています。生物学的安全キャビネットは、バイオセーフティキャビネットとしても知られています。これは、病原体に汚染された要素を安全に扱うことを可能にする密閉された換気作業スペースであり、指定されたバイオセーフティレベルを必要とします。市場の成長を支えるその他の要因としては、慢性疾患治療のための個別化医療に対する需要の高まりと、慢性疾患を抱える高齢化人口の増加が挙げられます。さらに、医療分野における研究開発活動の活発化や、さまざまな新技術の採用が増加していることも、市場成長の要因となっています。

市場概要
予測期間 2026年~2030年
市場規模:2024年 2億8,726万米ドル
市場規模:2030年 4億5,587万米ドル
CAGR:2025年~2030年 8.00%
急成長セグメント 診断・検査ラボ
最大市場 北米

市場促進要因

病原体調査におけるラボのバイオセーフティ意識の高まり

主な市場課題

初期コストと運用コストの高さ

主要市場動向

スマートでエネルギー効率の高いBSC設計の革新

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の生物学的安全キャビネット市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • タイプ別(クラスI、クラスII、クラスIII)
    • エンドユーザー別(製薬・バイオ医薬品企業、診断・検査機関、学術・研究機関)
    • 地域別
    • 企業別(2024年)
  • 市場マップ
    • タイプ別
    • エンドユーザー別
    • 地域別

第6章 北米の生物学的安全キャビネット市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米:国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の生物学的安全キャビネット市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州:国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋の生物学的安全キャビネット市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋:国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米の生物学的安全キャビネット市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの生物学的安全キャビネット市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 製品上市
  • 合併と買収

第13章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威/サービス

第14章 世界の生物学的安全キャビネット市場:SWOT分析

第15章 競合情勢

  • Thermo Fisher Scientific, Inc.
  • Labconco Corp.
  • NuAire, Inc.
  • The Baker Company, Inc.
  • Haier Biomedical(Qingdao Biomedical Co., Ltd.)
  • Cruma S.A.
  • Jinan Biobase Biotech Co. Ltd.
  • Azbil Telstar
  • Germfree Laboratories, Inc.
  • Air Science, Inc.

第16章 戦略的提言

第17章 調査会社について・免責事項

目次
Product Code: 14330

Global Biological Safety Cabinet Market was valued at USD 287.26 million in 2024 and is expected to reach USD 455.87 million by 2030 with a CAGR of 8.00% during the forecast period. The global market for Biological Safety Cabinet is experiencing significant growth, driven by the rising risk of communicable diseases and increasing research and development activities in biotechnology and pharmaceutical companies. Biological Safety Cabinets is also known as biosafety cabinets. It is an enclosed ventilated workspace that enables safety working with elements contaminated with pathogens, which requires a designated biosafety level. The other factors supporting the market's growth are the growing demand for personalized medicine for the treatment of chronic diseases, and the growing aging population with chronic diseases. Moreover, the rise in the research and development activities in the medical sector and the rise in the adoption of various new technologies are the contributing factors to the growth of the market.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 287.26 Million
Market Size 2030USD 455.87 Million
CAGR 2025-20308.00%
Fastest Growing SegmentDiagnostics & Testing Laboratories
Largest MarketNorth America

Key Market Drivers

Escalating Awareness of Lab Biosafety in Pathogen Research

The recent focus on high-risk pathogen handling-especially following outbreaks such as COVID 19, Ebola, and anthrax lapses-has catalyzed a global push towards safer laboratory environments. Biosafety cabinets are central to these efforts, offering primary containment to reduce staff exposure and environmental pollution. In the United States, repeated audits by the CDC and Department of Health have highlighted biosafety lapses, prompting reforms and procedural overhauls. International bodies such as the World Health Organization (WHO) also stress strict biosafety practices. For example, in 2023 WHO supported certification training in Nepal to strengthen national biosafety capacity. As pandemic preparedness becomes a policy priority, national health agencies are investing in BSCs-especially Class II and III-to ensure safe handling of emerging pathogens. Such measures align with recommended biosafety upgrade plans and global health compliance frameworks, boosting BSC market demand.

Key Market Challenges

High Initial and Operational Costs

Despite regulatory backing, cost remains a barrier for many laboratories. Advanced Class II and III units-with HEPA filters, air handling ducting, and smart electronics-can be prohibitively expensive, especially in resource-limited settings. Even after purchase, recurring costs related to HEPA filter replacements, airflow testing equipment, and annual NSF/ANSI certifications add up.

Improper or inadequate installation, lack of trained personnel, and budget constraints can reduce compliance. As noted in Southeast Asian labs, ~30% of BSCs were found to be mis installed or improperly maintained. Without sustained funding, especially in low-income institutions, these safety-critical systems may lapse into disuse or underperformance-posing regulatory and biohazard risks.

Key Market Trends

Innovation in Smart, Energy-Efficient BSC Designs

A major ongoing trend is the rise of smart, energy-efficient biosafety cabinets. Manufacturers are integrating digital airflow monitoring, automated sash control, and IoT-enabled alerts for filter replacement or airflow disruptions. Some advanced models self-adjust airflow when idle, reducing energy usage by up to 30%, along with LED lighting and efficient motors that further cut operating costs.

Cabinets designed to fit in space-constrained microbiology or pharmaceutical labs-often with laminar and containment airflow modes-are gaining popularity. These smart and sustainable innovations align with institutional goals to improve safety while minimizing carbon footprint and operational expense, signaling a shift toward eco-conscious laboratory design.

Key Market Players

  • Thermo Fisher Scientific, Inc.
  • Labconco Corp.
  • NuAire, Inc.
  • The Baker Company, Inc.
  • Haier Biomedical (Qingdao Biomedical Co., Ltd.)
  • Cruma S.A.
  • Jinan Biobase Biotech Co. Ltd.
  • Azbil Telstar
  • Germfree Laboratories, Inc.
  • Air Science, Inc.

Report Scope:

In this report, the Global Biological Safety Cabinet Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biological Safety Cabinet Market, By Type:

  • Class I
  • Class II
  • Class III

Biological Safety Cabinet Market, By End User:

  • Pharmaceutical & Biopharmaceutical Companies
  • Diagnostics & Testing Laboratories
  • Academic & Research Organizations

Biological Safety Cabinet Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Biological Safety Cabinet Market.

Available Customizations:

Global Biological Safety Cabinet Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biological Safety Cabinet Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Class I, Class II, Class III)
    • 5.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map
    • 5.3.1. By Type
    • 5.3.2. By End User
    • 5.3.3. By Region

6. North America Biological Safety Cabinet Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Class I, Class II, Class III)
    • 6.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Biological Safety Cabinet Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Biological Safety Cabinet Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Biological Safety Cabinet Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End User

7. Europe Biological Safety Cabinet Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Class I, Class II, Class III)
    • 7.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Biological Safety Cabinet Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End User
    • 7.3.2. Germany Biological Safety Cabinet Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Biological Safety Cabinet Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Biological Safety Cabinet Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Biological Safety Cabinet Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End User

8. Asia-Pacific Biological Safety Cabinet Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Class I, Class II, Class III)
    • 8.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Biological Safety Cabinet Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End User
    • 8.3.2. India Biological Safety Cabinet Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Biological Safety Cabinet Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Biological Safety Cabinet Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Biological Safety Cabinet Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End User

9. South America Biological Safety Cabinet Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Class I, Class II, Class III)
    • 9.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Biological Safety Cabinet Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End User
    • 9.3.2. Argentina Biological Safety Cabinet Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End User
    • 9.3.3. Colombia Biological Safety Cabinet Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End User

10. Middle East and Africa Biological Safety Cabinet Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Class I, Class II, Class III)
    • 10.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Biological Safety Cabinet Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Saudi Arabia Biological Safety Cabinet Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End User
    • 10.3.3. UAE Biological Safety Cabinet Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products/Services

14. Global Biological Safety Cabinet Market: SWOT Analysis

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Labconco Corp.
  • 15.3. NuAire, Inc.
  • 15.4. The Baker Company, Inc.
  • 15.5. Haier Biomedical (Qingdao Biomedical Co., Ltd.)
  • 15.6. Cruma S.A.
  • 15.7. Jinan Biobase Biotech Co. Ltd.
  • 15.8. Azbil Telstar
  • 15.9. Germfree Laboratories, Inc.
  • 15.10. Air Science, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer